Cefroxadina--un nuovo antibiotico. Sperimentazione clinica.

Translated title of the contribution: Cephroxadine--a new antibiotic. Clinical experience

Research output: Contribution to journalArticle

Abstract

Cephroxadine is an orally active cephalosporin of third generation. The most important characteristics are: 1) bacterial cell wall synthesis inhibition during active multiplication; 2) wide spectrum of action, including Gram+ and Gram- bacteria and also penicillinase and beta-lactamase producers; 3) possibility of oral administration, quick assimilation and daily moderate dosage (500 mg/12 h). This antibiotic was tested on 71 patients to prevent and resolve dental pre-and post-operating infections. In all tested cases Cephroxadine was very effective and resolved well symptoms on second day, generally. Moreover no patient had any collateral effect to justify interruption of therapy.

Original languageItalian
Pages (from-to)60-74
Number of pages15
JournalDental Cadmos
Volume57
Issue number9
Publication statusPublished - May 31 1989

Fingerprint

Anti-Bacterial Agents
Penicillinase
Cephalosporins
beta-Lactamases
Cell Wall
Oral Administration
Tooth
Bacteria
Infection
Therapeutics
Action Spectrum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cefroxadina--un nuovo antibiotico. Sperimentazione clinica. / Gherlone, E. F.

In: Dental Cadmos, Vol. 57, No. 9, 31.05.1989, p. 60-74.

Research output: Contribution to journalArticle

@article{5e72ec4064284039b54521c1271cd423,
title = "Cefroxadina--un nuovo antibiotico. Sperimentazione clinica.",
abstract = "Cephroxadine is an orally active cephalosporin of third generation. The most important characteristics are: 1) bacterial cell wall synthesis inhibition during active multiplication; 2) wide spectrum of action, including Gram+ and Gram- bacteria and also penicillinase and beta-lactamase producers; 3) possibility of oral administration, quick assimilation and daily moderate dosage (500 mg/12 h). This antibiotic was tested on 71 patients to prevent and resolve dental pre-and post-operating infections. In all tested cases Cephroxadine was very effective and resolved well symptoms on second day, generally. Moreover no patient had any collateral effect to justify interruption of therapy.",
author = "Gherlone, {E. F.}",
year = "1989",
month = "5",
day = "31",
language = "Italian",
volume = "57",
pages = "60--74",
journal = "Dental Cadmos",
issn = "0011-8524",
publisher = "Masson SpA",
number = "9",

}

TY - JOUR

T1 - Cefroxadina--un nuovo antibiotico. Sperimentazione clinica.

AU - Gherlone, E. F.

PY - 1989/5/31

Y1 - 1989/5/31

N2 - Cephroxadine is an orally active cephalosporin of third generation. The most important characteristics are: 1) bacterial cell wall synthesis inhibition during active multiplication; 2) wide spectrum of action, including Gram+ and Gram- bacteria and also penicillinase and beta-lactamase producers; 3) possibility of oral administration, quick assimilation and daily moderate dosage (500 mg/12 h). This antibiotic was tested on 71 patients to prevent and resolve dental pre-and post-operating infections. In all tested cases Cephroxadine was very effective and resolved well symptoms on second day, generally. Moreover no patient had any collateral effect to justify interruption of therapy.

AB - Cephroxadine is an orally active cephalosporin of third generation. The most important characteristics are: 1) bacterial cell wall synthesis inhibition during active multiplication; 2) wide spectrum of action, including Gram+ and Gram- bacteria and also penicillinase and beta-lactamase producers; 3) possibility of oral administration, quick assimilation and daily moderate dosage (500 mg/12 h). This antibiotic was tested on 71 patients to prevent and resolve dental pre-and post-operating infections. In all tested cases Cephroxadine was very effective and resolved well symptoms on second day, generally. Moreover no patient had any collateral effect to justify interruption of therapy.

UR - http://www.scopus.com/inward/record.url?scp=0024981869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024981869&partnerID=8YFLogxK

M3 - Articolo

C2 - 2639806

AN - SCOPUS:0024981869

VL - 57

SP - 60

EP - 74

JO - Dental Cadmos

JF - Dental Cadmos

SN - 0011-8524

IS - 9

ER -